A detailed history of Wells Fargo & Company transactions in Global X Fds Genomics & Biotec stock. As of the latest transaction made, Wells Fargo & Company holds 1 shares of GNOM stock, worth $10. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 0 Infinity%
Holding current value
$10
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$9.68 - $11.36 $9 - $11
1 New
1 $0
Q1 2024

May 10, 2024

BUY
$10.75 - $12.29 $0 - $0
0 New
0 $0
Q4 2023

Feb 09, 2024

BUY
$8.77 - $11.77 $0 - $0
0 New
0 $0
Q3 2023

Nov 13, 2023

BUY
$10.07 - $12.5 $0 - $0
0 New
0 $0
Q2 2023

Aug 15, 2023

BUY
$11.99 - $13.07 $0 - $0
0 New
0 $0
Q1 2023

May 12, 2023

SELL
$11.73 - $14.18 $11 - $14
-1 Closed
0 $0
Q2 2022

Aug 12, 2022

BUY
$10.66 - $15.9 $10 - $15
1 New
1 $0
Q1 2022

May 16, 2022

SELL
$13.33 - $19.98 $19,995 - $29,970
-1,500 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$19.42 - $22.42 $29,130 - $33,630
1,500 New
1,500 $30,000
Q3 2021

Nov 15, 2021

SELL
$21.89 - $25.16 $21 - $25
-1 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$19.75 - $24.89 $19 - $24
1 New
1 $0
Q1 2021

May 13, 2021

BUY
$21.08 - $27.89 $0 - $0
0 New
0 $0

Others Institutions Holding GNOM

About GLOBAL X FDS GENOMICS & BIOTEC


  • Ticker GNOM
  • Sector ETFs
  • Industry ETFs
More about GNOM
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.